Home » Authors » Karen Young

Articles by Karen Young

Athersys Extends, Expands Deal To Deliver Cell Lines For BMS

Aug. 6, 2002

Athersys Extends, Expands Deal To Deliver Cell Lines For BMS

Aug. 6, 2002

Alnylam Raises $15 In Series B For Work In RNA Interference

Aug. 5, 2002

Alnylam Raises $15 In Series B For Work In RNA Interference

Aug. 5, 2002

Biopure Files Hemopure BLA For Symptoms Of Acute Anemia

Aug. 2, 2002

Biopure Files Hemopure BLA For Symptoms Of Acute Anemia

Aug. 2, 2002

NeoGenesis, Pharmacia Enter Discovery, Development Deal

Aug. 1, 2002

Zyomyx Completes $27M Round For Protein Biochip Technology

Aug. 1, 2002

NeoGenesis, Pharmacia Enter Discovery, Development Deal

Aug. 1, 2002

Zyomyx Completes $27M Round For Protein Biochip Technology

Aug. 1, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 9, 2025
STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space
BioWorld
Kaken Pharmaceutical Co. Ltd.’s license agreement with Johnson & Johnson (J&J) for signal transducer and activator of transcription (STAT)6 inhibitor KP-723 could...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...
Australia’s Celosia heads toward clinic with gene therapy for ALS
BioWorld
After raising AU$16.75 million (US$10.4 million) in a series A round, Celosia Therapeutics Pty Ltd. is heading toward the clinic with its novel gene therapy that...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.